InspireMD Company Overview
CGuard™ EPS vs conventional stents and surgery InspireMD
•
CGuard™ is a widely researched next generation carotid device stent (7 completed clinical trials and
4 ongoing trials)
•
CGuard™ shows strong benefits compared to both conventional carotid stents and surgery
•
Long term sustained and consistent benefit (MACCE 0.9% @ 12 months)4
30 day MACCE results (Major and Minor
Adverse Cardiac and Cerebral Events)
6.00%
5.00%
4.00%
3.00%
2.00%
(1,2)
1.00%
0.76%
0.00%
CGuard™
5.20% (3)
4.50% (3)
Conventional stents
CEA
*NOTE: IRON-GUARD, Wisggott and Casana trials are not included in this calculation of the CGuard data as these trials were not independently monitored
1 JACC Cardiovasc Interv 2015 Aug 17. 8:1229-1234
2 EuroIntervention 2016 Aug 05. 658-70
3 N Engl J of Med 2010 July 1. 11-23
4 Musialek et. al. TCT 2016 Featured Research Presentation
14View entire presentation